RELX Reports FY 2023 Revenue Growth Amid AI Impact
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Should l Buy RELX?
Source: seekingalpha
- Financial Performance: RELX reported FY 2023 revenue of £9.59 billion, up 1.4% from £9.434 billion in FY 2022, demonstrating the company's stability and resilience in the market.
- Profitability Improvement: The adjusted earnings per share (EPS) rose to 128.5 pence, a 5.8% increase from 120.1 pence the previous year, reflecting successful cost control and operational efficiency.
- Market Reaction: Despite revenue and profit growth, analysts express caution regarding enterprise software stocks, suggesting that AI impacts may accelerate market volatility, leading to potential downside pressure on RELX shares.
- Investment Rating: Analysts maintain a 'Hold' rating on RELX, indicating confidence in its long-term growth potential, particularly in the evolving technological landscape.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RELX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RELX
Wall Street analysts forecast RELX stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 35.680
Low
60.54
Averages
60.54
High
60.54
Current: 35.680
Low
60.54
Averages
60.54
High
60.54
About RELX
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Weak Economic Growth: The UK GDP expanded by only 0.1% in Q4 2025, indicating the fragility of the recovery after nearly two years of stagnation, which raises uncertainty for investors regarding the sustainability of growth.
- Inflation and Interest Rate Dynamics: Inflation has eased to 3.0%, down from 3.4% the previous month, allowing the Bank of England to cut interest rates by approximately 1.5 percentage points since mid-2024, although the benchmark rate remains at 3.75%, providing some relief for households and policymakers.
- Unemployment and Public Debt Pressure: The unemployment rate has risen to 5.2%, an increase of about 331,000 year-over-year, while public debt stands at 92.9% of GDP, limiting the government's fiscal flexibility and indicating ongoing economic strain.
- Sector Investment Outlook: By 2026, investment in strategic sectors such as clean energy, infrastructure, and advanced manufacturing is expected to significantly increase, with annual investment in clean energy projected to exceed £40 billion, highlighting these areas as key drivers for future economic recovery.
See More
- Enhanced Verification Capabilities: LexisNexis Risk Solutions announced the expansion of its integration with Epic, introducing new identity verification solutions aimed at improving security and user experience in Epic MyChart, thereby enabling hospitals to manage patient access more effectively.
- Flexible Solution Combinations: U.S. hospitals can select various identity verification components based on their risk requirements, ensuring that only verified users can access patient portals, which enhances the security and privacy of patient data.
- AI-Driven Verification Technology: Future integration will include LexisNexis® IDVerse®, an AI-powered identity verification solution capable of detecting deepfakes and forged documents, supporting a dynamic NIST IAL2-certified workflow that further enhances security.
- Trust in the Industry: Jonathan Shannon, VP of healthcare strategy, stated that this integration not only improves user experience but also strengthens trust between healthcare organizations and patients, helping organizations maintain a balance of security and convenience in the face of cybercrime threats.
See More
- Enhanced Verification Capabilities: LexisNexis Risk Solutions announced an expansion of its integration with Epic, introducing new identity verification solutions aimed at improving security and user experience in U.S. hospitals, ensuring that only verified users can access patient portals.
- Diverse Solution Options: Through the Epic Connection Hub, hospitals can flexibly select and combine various identity verification components based on their risk requirements, thereby reducing risk and enhancing the security of patient access, which improves operational efficiency.
- AI-Driven Verification Technology: The new integration will include LexisNexis® IDVerse®, an AI-powered identity verification solution capable of detecting forgeries and fraud, supporting a dynamic workflow that meets NIST IAL2 standards, further elevating security standards in the healthcare industry.
- Market Demand Response: As cybercrime threats to the healthcare sector intensify, this integration not only addresses the dual needs for security and user experience but also showcases LexisNexis's leadership in providing innovative solutions, thereby enhancing customer trust.
See More
- Leadership Recognition: LexisNexis Risk Solutions has been named a Leader in the IDC MarketScape for U.S. Provider Data Management for the second consecutive year, highlighting its exceptional performance in data quality and compliance, which enhances its competitive position in the healthcare sector.
- Unique Data Management Approach: The company employs a nontraditional master data management method that dynamically builds 'golden records' using proprietary linking technology, allowing it to adapt to new inputs and ensure data quality, thereby increasing client trust and satisfaction.
- Extensive Data Coverage: LexisNexis's database supports over 3.7 billion transactions annually for prescriber compliance verification, and as healthcare providers and pharmacies merge, the breadth and depth of its data will continue to increase, further enhancing its value to payers.
- Commitment to Quality: LexisNexis is dedicated to delivering high-quality data management solutions, and with the rising implementation of automated workflows and growing security concerns, its investments in data quality, timeliness, and flexibility will drive better health outcomes.
See More

- Market Leadership: LexisNexis Risk Solutions has been recognized as a Leader in the IDC MarketScape for U.S. Provider Data Management for Payers for the second consecutive year, showcasing its exceptional capabilities and influence in the data management sector.
- Commitment to Data Quality: IDC highlighted LexisNexis's strengths in data volume, quality, and completeness, emphasizing its dedication to providing high-quality data for payers, which is crucial for improving health outcomes.
- Technological Investments: The company's significant investments in automated workflow solutions and data security further solidify its leadership position in the healthcare industry, ensuring clients receive timely and flexible data management solutions.
- Industry Recognition: LexisNexis's Provider Data Management Suite has been highly rated for its comprehensive data quality and compliance, reflecting its strategic importance in meeting the needs of payers.
See More
- Platform Launch: LexisNexis has unveiled an identity management platform tailored for the healthcare sector, integrating leading identity verification and enrichment solutions to enhance the efficiency and accuracy of patient identity management, thereby improving operational capabilities and patient experiences for healthcare organizations.
- Fraud Risk Reduction: The platform employs AI-driven IDVerse® technology to effectively detect deepfake identities, mitigating identity fraud risks and ensuring security and trust for patients and members throughout their healthcare journey, ultimately enhancing the quality of medical services.
- Enhanced Patient Experience: By streamlining identity management processes, the platform supports patient registration and claims processing, reduces manual workloads, and improves digital experiences, helping healthcare organizations increase patient engagement and satisfaction while ensuring security.
- Addressing Digital Challenges: As digital services expand, healthcare organizations face fragmentation and inaccuracies in the identity verification process; this platform provides comprehensive identity verification solutions that help organizations manage patient identities securely without adding burdens to users.
See More







